Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2010-7-28
pubmed:databankReference
pubmed:abstractText
We report the safety findings from a 3-year phase 3 study (NCT00205777) of bazedoxifene, a novel selective estrogen receptor modulator under development for the prevention and treatment of postmenopausal osteoporosis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-10214833, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-10376571, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-10517716, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-11146381, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-11795370, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-12036407, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-15458908, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-15932835, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-15961563, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-16735931, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-16754727, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-16837676, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-18072873, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-18087050, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-18665787, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-19543129, http://linkedlifedata.com/resource/pubmed/commentcorrection/20569451-19546825
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1471-2474
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
130
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis.
pubmed:affiliation
Center for Clinical and Basic Research, Ballerup, Denmark. cc@Nordicbioscience.com
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III